Cargando…

The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study

BACKGROUND: Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Youwei, Peng, Wei, Shen, Junyi, Zhang, Xiaoyun, Li, Chuan, Wen, Tianfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118788/
https://www.ncbi.nlm.nih.gov/pubmed/35585534
http://dx.doi.org/10.1186/s12893-022-01643-7
_version_ 1784710573174292480
author Wu, Youwei
Peng, Wei
Shen, Junyi
Zhang, Xiaoyun
Li, Chuan
Wen, Tianfu
author_facet Wu, Youwei
Peng, Wei
Shen, Junyi
Zhang, Xiaoyun
Li, Chuan
Wen, Tianfu
author_sort Wu, Youwei
collection PubMed
description BACKGROUND: Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has not been clarified. METHODS: From January 2009 to March 2015, 171 patients who underwent initial hepatectomy and second curative treatments in West China Hospital were retrospectively analyzed. Survival analysis was performed by the Kaplan–Meier method. Risk factors were identified using the Cox proportional hazard model. RESULTS: At initial hepatectomy, 96 patients (56.1%) were diagnosed with HCC within the Milan criteria (MC), and 75 patients (43.9%) were HCC beyond the MC. The clinicopathological features and re-treatment methods of recurrent HCC were similar between patients with primary HCC within or beyond the MC. Patients with primary HCC within the MC had longer recurrence time (31.4 ± 24.2 months vs. 20.2 ± 16 months, P < 0.001). The 1- and 3- year RTDS within and beyond the MC group were 88.8%, 57.6% and 79.0%, 46.3%, respectively (P = 0.093). In multivariate analysis, the recurrence time, tumor size and AFP > 400 ng/mL at the time of recurrence were associated with RTDS. CONCLUSIONS: The primary tumor burden had no impact on RTDS, but had an impact on recurrence time. The recurrence time had an impact on RTDS and might be a good index to reflect the biology of recurrent HCC.
format Online
Article
Text
id pubmed-9118788
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91187882022-05-20 The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study Wu, Youwei Peng, Wei Shen, Junyi Zhang, Xiaoyun Li, Chuan Wen, Tianfu BMC Surg Research BACKGROUND: Previous studies have reported the surgical resection (SR) and radiofrequency ablation (RFA) could achieve comparable recurrence-to-death survival (RTDS). However, the impact of primary tumor burden on RTDS of patients with recurrent hepatocellular carcinoma (HCC) following SR or RFA has not been clarified. METHODS: From January 2009 to March 2015, 171 patients who underwent initial hepatectomy and second curative treatments in West China Hospital were retrospectively analyzed. Survival analysis was performed by the Kaplan–Meier method. Risk factors were identified using the Cox proportional hazard model. RESULTS: At initial hepatectomy, 96 patients (56.1%) were diagnosed with HCC within the Milan criteria (MC), and 75 patients (43.9%) were HCC beyond the MC. The clinicopathological features and re-treatment methods of recurrent HCC were similar between patients with primary HCC within or beyond the MC. Patients with primary HCC within the MC had longer recurrence time (31.4 ± 24.2 months vs. 20.2 ± 16 months, P < 0.001). The 1- and 3- year RTDS within and beyond the MC group were 88.8%, 57.6% and 79.0%, 46.3%, respectively (P = 0.093). In multivariate analysis, the recurrence time, tumor size and AFP > 400 ng/mL at the time of recurrence were associated with RTDS. CONCLUSIONS: The primary tumor burden had no impact on RTDS, but had an impact on recurrence time. The recurrence time had an impact on RTDS and might be a good index to reflect the biology of recurrent HCC. BioMed Central 2022-05-18 /pmc/articles/PMC9118788/ /pubmed/35585534 http://dx.doi.org/10.1186/s12893-022-01643-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Youwei
Peng, Wei
Shen, Junyi
Zhang, Xiaoyun
Li, Chuan
Wen, Tianfu
The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
title The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
title_full The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
title_fullStr The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
title_full_unstemmed The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
title_short The impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
title_sort impact of tumor burden at the initial hepatectomy on the recurrence-to-death survival after repeat surgical resection/radiofrequency ablation: a retrospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118788/
https://www.ncbi.nlm.nih.gov/pubmed/35585534
http://dx.doi.org/10.1186/s12893-022-01643-7
work_keys_str_mv AT wuyouwei theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT pengwei theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT shenjunyi theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT zhangxiaoyun theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT lichuan theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT wentianfu theimpactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT wuyouwei impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT pengwei impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT shenjunyi impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT zhangxiaoyun impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT lichuan impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy
AT wentianfu impactoftumorburdenattheinitialhepatectomyontherecurrencetodeathsurvivalafterrepeatsurgicalresectionradiofrequencyablationaretrospectivestudy